Liver Cancer Prognosis Investigation Study

Launched by SUN YAT-SEN UNIVERSITY · Oct 1, 2024

Keywords

ClinConnect Summary

The Liver Cancer Prognosis Investigation Study is a research project aimed at understanding how different factors, such as the environment, health history, and genetics, affect the progression and outlook of primary liver cancer. The study will enroll 5,000 patients who have just been diagnosed with this type of cancer and have not yet received any treatment. Participants will fill out a survey when they first join the study and will be checked on every 3 to 6 months after they leave the hospital.

To be eligible for the study, participants need to be between 18 and 80 years old and must have a confirmed diagnosis of primary liver cancer, meaning they haven't had any prior cancer treatments. However, individuals with other serious health issues, a history of other cancers, or those who may not live longer than three months are not eligible. This study could help improve understanding of liver cancer and potentially lead to better treatment options in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18-80 years,
• • Diagnosed with primary liver cancer (ICD-10: C22) (Referring to the diagnostic criteria in the "Primary Liver Cancer Diagnosis and Treatment Guidelines (2024 Edition)" and the "2024 CSCO Guidelines for the Diagnosis and Treatment of Biliary Malignancies),
• • Have not received any anti-tumor treatment (e.g., surgery, ablation, interventional therapy, radiotherapy, chemotherapy, targeted therapy, immunotherapy, etc),
• • Signed informed consent.
• Exclusion Criteria:
• • Have a history of other malignant tumors,
• • Have a history of other serious chronic diseases (e.g., heart failure, liver failure, kidney failure, etc.),
• • Expected survival time is no more than 3 months,
• • Severe physical or mental disability.